{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-002772","form_type":"8-K","ticker":"IDXG","cik":"0001054102","company_name":"INTERPACE BIOSCIENCES, INC.","filed_at":"2026-01-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.474522+00:00","generated_at":"2026-05-16T09:28:32.449651+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Interpace Biosciences Announces Preliminary 2025 Revenue, 2026 Guidance, and Preferred Stock Conversion","bullets":["Preliminary 2025 thyroid testing revenue of ~$34-35M, up 21% over prior year.","Company initiates 2026 revenue guidance of ~$40M, representing 16% growth in thyroid testing.","All outstanding Series C Preferred Stock converted into common stock at $2.02 per share, issuing ~23.3M shares.","Company is debt-free with positive net income and EBITDA, plans to seek uplisting to Nasdaq in 2026.","Following conversion, pro forma basic shares outstanding ~27.7M; 1315 Capital owns ~34%, Ampersand owns ~50%."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-002772","json":"https://secwatch.observer/filing/0001493152-26-002772.json","markdown":"https://secwatch.observer/filing/0001493152-26-002772.md","text":"https://secwatch.observer/filing/0001493152-26-002772.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1054102/000149315226002772/0001493152-26-002772-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1054102/000149315226002772/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-16T09:28:32.449651+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}